相关实验视频
Updated: May 22, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.0K
阿托瓦斯塔丁减弱了皮病患者的损伤相关分子模式和炎症性细胞因子的表达
Kalliopi Armyra1, Amin M Ektesabi2, James N Tsoporis3
1First Department of Dermatology and Venereology, Andreas Syggros Hospital, University of Athens, Athens, Greece.
Pharmacological reports : PR
|March 14, 2025
概括
在牛皮患者中,阿托瓦斯塔丁治疗减少了与血损伤相关的分子模式 (DAMPs) 和炎症性细胞因子,改善了疾病的严重程度. 这表明他类药物可以有效降低牛皮中DAMP诱导的炎症.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 牛皮涉及由损伤相关分子模式 (DAMPs) 触发的炎症反应.
- 类药物除了降低胆固醇之外,还具有抗炎性质.
- 这项研究研究了阿托瓦斯塔丁在牛皮中对DAMP和细胞因子的影响.
研究的目的:
- 评估阿托瓦斯塔丁在减少成年牛皮患者血DAMP和炎症性细胞因子方面的疗效.
- 评估阿托瓦斯塔丁对牛皮严重程度和生活质量的影响.
主要方法:
- 一项为期3个月的前性研究,涉及21名接受阿托瓦斯塔丁 (10毫克/天) 治疗的牛皮患者和14名对照患者.
- 血DAMP和炎症性细胞因子水平在基线和3个月后被测量.
- 牛皮的严重程度和生活质量得分使用牛皮严重程度指数和皮肤病特异性生活质量指数进行评估.
主要成果:
- 牛皮血显示了S100B,S100A7,S100A12,S100A8/A9,DJ-1,IL-6,IL-1β和TNF-α的水平升高,并减少了高级糖化终产品 (sRAGE) 的可溶性受体.
- 阿托瓦斯塔丁治疗改善了疗效得分,增加了sRAGE,并减少了DAMPs和炎症性细胞因子.
- 在体外研究表明S100A7和S100A12诱导炎症,而阿托瓦斯塔丁增加了sRAGE.
结论:
- 立方体治疗,特别是阿托瓦斯塔丁,有效地缓解了牛皮中DAMP诱导的炎症.
- 阿托瓦斯塔丁治疗导致了临床结果的改善,并减少了关键的炎症标志物.
- 建议进行较大的队列研究,以证实这些发现,因为样本大小小.
相关概念视频
T Cell Types and Functions
740
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
740
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Inflammation
52.1K
Overview
52.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
141
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
141

